BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Julphar
UBS
Colorcon
Baxter
Medtronic
Dow
Covington
AstraZeneca
McKesson

Generated: January 19, 2018

DrugPatentWatch Database Preview

PROGLYCEM Drug Profile

« Back to Dashboard

Which patents cover Proglycem, and what generic alternatives are available?

Proglycem is a drug marketed by Teva Branded Pharm and is included in two NDAs.

The generic ingredient in PROGLYCEM is diazoxide. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diazoxide profile page.
Drug patent expirations by year for PROGLYCEM
Medical Subject Heading (MeSH) Categories for PROGLYCEM

US Patents and Regulatory Information for PROGLYCEM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm PROGLYCEM diazoxide CAPSULE;ORAL 017425-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Branded Pharm PROGLYCEM diazoxide CAPSULE;ORAL 017425-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Branded Pharm PROGLYCEM diazoxide SUSPENSION;ORAL 017453-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
US Army
Fish and Richardson
Cantor Fitzgerald
Cerilliant
Accenture
Cipla
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot